Israeli guidelines for the management of hypercholesterolemia in children and adolescents. Report of the pediatric association expert group

e-SPEN

Volumn 5, Issue 3, 2010, Pages

  Cohen, Hofit ^a,e   Stein Zamir, Chen ^b,f   Hamiel, Orit ^a,e   Lebenthal, Yael ^c,e   Schurr, Daniel ^d   Harats, Dror ^a,e   Shamir, Raanan ^c,e  

^a SHEBA MEDICAL CENTER   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

^f HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Atherosclerosis; Children and adolescents; Coronary heart disease; Hypercholesterolemia; Pediatric hyperlipidemia

Indexed keywords

BILE ACID; COLESTIPOL; COLESTYRAMINE; DOCOSAHEXAENOIC ACID; EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; OMEGA 3 FATTY ACID; PLACEBO; SIMVASTATIN; SOYBEAN PROTEIN; STANOL ESTER;

ADOLESCENT; ARTICLE; CHILD; CHILD DEVELOPMENT; CHILD GROWTH; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIET THERAPY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG WITHDRAWAL; DYSLIPIDEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; FAT INTAKE; GARLIC; GASTROINTESTINAL SYMPTOM; HIGH RISK PATIENT; HOT FLUSH; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; ISRAEL; LIFESTYLE MODIFICATION; LIVER FUNCTION; LIVER TOXICITY; MASS SCREENING; MUSCLE DISEASE; MYALGIA; NUTRITIONAL ASSESSMENT; NUTRITIONAL COUNSELING; OBESITY; PATIENT ASSESSMENT; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PUBERTY; RASH; RHABDOMYOLYSIS; SCREENING TEST; SIDE EFFECT;

EID: 77951879121     PISSN: 17514991     EISSN: 17514991     Source Type: Journal    
DOI: 10.1016/j.eclnm.2010.03.003     Document Type: Article

References (82)

1. Enos W.F., Holmes R.H., and Beyer J. Coronary disease among United States soldiers killed in action in Korea: preliminary report. J Am Med Assoc 152 (1953) 1090-1093
2. Strong J.P. Coronary atherosclerosis in soldiers: a clue to the natural history of atherosclerosis in the young. J Am Med Assoc 256 (1986) 2863-2866
3. Strong J.P., Malcom G.T., McMahan C.A., Tracy R.E., Newman III W.P., Herderick E.E., et al. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the pathobiological determinants of atherosclerosis in youth study. J Am Med Assoc 281 (1999) 727-735
4. Napoli C., Glass C.K., Witztum J.L., Deutsch R., D'Armiento F.P., and Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: fate of early lesions in children (FELIC) study. Lancet 354 9186 (1999) 1234-1241
5. Berenson G.S., Srinivasan S.R., Bao W., Newman III W.P., Tracy R.E., and Wattigney W.A. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 338 23 (1998) 1650-1656
6. Cannon C.P., Braunwald E., McCabe C.H., Rader D.J., Rouleau J.L., Belder R., et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350 (2004) 1495-1504
7. Versmissen J., Oosterveer D.M., Yazdanpanah M., Defesche J.C., Basart D.C., Liem A.H., et al. Efficacy of statins in familial hypercholesterolaemia: a long-term cohort study. BMJ 337 (2008) a2423
8. Jemal A., Ward E., Hao Y., and Thun M. Trends in the leading causes of death in the United States, 1970-2002. J Am Med Assoc 294 10 (2005) 1255-1259
9. Avis H.J., Vissers M.N., Stein E.A., Wijburg F.A., Trip M.D., Kastelein J.J., et al. A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 27 (2007) 1803-1810
10. Reshef A., Nissen H., Triger L., Hensen T.S., Eliav O., Schurr D., et al. Molecular genetics of familial hypercholesterolemia in Israel. Hum Genet 98 (1996) 581-586
11. Kwiterovich P.O. Recognition and management of dyslipidemia in children and adolescents. J Clin Endocrinol Metab 93 11 (2008) 4200-4209
12. Rodenburg J. Statin treatment in children with familial hypercholesterolemia the younger, the better. Circulation 116 (2007) 664-668
13. de Jongh S., Lilien M.R., op't Roodt J., Stroes E.S., Bakker H.D., and Kastelein J.J. Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J Am Coll Cardiol 40 12 (2002) 2117-2121
14. van der Graaf A., Nierman M.C., Firth J.C., Wolmarans K.H., Marais A.D., and de Groot E. Efficacy and safety of fluvastatin in children and adolescents with heterozygous familial hypercholesterolaemia. Acta Paediatr 95 11 (2006) 1461-1466
15. McCrindle B.W., Urbina E.M., Dennison B.A., Jacobson M.S., Steinberger J., Rocchini A.P., et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing. Circulation 115 14 (2007) 1948-1967
16. Daniels S.R., Greer F.R., and Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics 122 1 (2008) 198-208
17. Cohen J.C., Boerwinkle E., Mosley Jr. T.H., and Hobbs H.H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 354 12 (2006) 1264-1272
18. Eisenberg D.A. Cholesterol lowering in the management of coronary artery disease: the clinical implications of recent trials. Am J Med 104 2A (1998) 2S-5S
19. Lipid Research Clinics Program. The Lipid Research Clinics Population Studies Data Book vol. 1 (1980), Government Printing Office, Washington DC DHHS publication NO. (NIH) 80-1527
20. National Cholesterol Education Program (NCEP): highlights of the report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 89 3 (1992) 495-501
21. Jolliffe C.J., and Janssen I. Distribution of lipoproteins by age and gender in adolescents. Circulation 114 (2006) 1056-1062
22. Cook S., Auinger P., and Huang T.T. Growth curves for cardio-metabolic risk factors in children and adolescents. J Pediatr 155 3 (2009) S6 e15-26
23. Webber L.S., Osganian V., Luepker R.V., Feldman H.A., Stone E.J., Elder J.P., et al. Cardiovascular risk factors among third grade children in four regions of the United States. The CATCH study: child and adolescent trial for cardiovascular health. Am J Epidemiol 141 5 (1995) 428-439
24. Hickman T.B., Briefel R.R., Carroll M.D., Rifkind B.M., Cleeman J.I., Maurer K.R., et al. Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey. Prev Med 27 6 (1998) 879-890
25. Ford E.S., Li C., Zhao G., and Mokdad A.H. Concentrations of low-density lipoprotein cholesterol and total cholesterol among children and adolescents in the United States. Circulation 119 8 (2009) 1108-1115
26. Bistritzer T., Batash D., Barr J., Rapoport M.J., Tamir D., Zaidman J.L., et al. Routine childhood screening for hyperlipidemia in Israel. Isr J Med Sci 32 9 (1996 Sep) 725-729
27. Ford E.S., Mokdad A.H., Giles W.H., and Mensah G.A. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 107 (2003) 2185-2189
28. American Heart Association. Heart disease and stroke statistics - 2004 update (2003), American Heart Association, Dallas, Tex
29. Haney E.M., Huffman L.H., Bougatsos C., Freeman M., Steiner R.D., Nelson H.D., et al. Screening for lipid disorders in children and adolescents: systematic evidence review for the U.S. Preventive Services Task Force. Evidence Synthesis Number 47 (July 2007), Agency for Healthcare Research and Quality, Rockville, Maryland. http://www.ahrq.gov/clinic/uspstf/uspschlip.htm
30. Lauer R.M., and Clarke W.R. Use of cholesterol measurements in childhood for the prediction of adult hypercholesterolemia: the Muscatine study. J Am Med Assoc 264 23 (1990) 3034-3038
31. Webber L.S., Srinivasan S.R., Wattigney W.A., and Berenson G.S. Tracking of serum, lipids, and lipoproteins from childhood to adulthood: the Bogalusa Heart Study. Am J Epidemiol 133 9 (1991) 884-899
32. Freedman D.S., Dietz W.H., Srinivasan S.R., and Berenson G.S. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics 103 (1999) 1175-1182
33. Srinvasan S.R., Bao W., Wattigney W.A., and Berenson G.S. Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors: the Bogalusa Heart Study. Metabolism 45 (1996) 235-240
34. Barlow S.E., Dietz W.H., Klish W.J., and Trowbridge F.L. Medical evaluation of overweight children and adolescents: reports from pediatricians, pediatric nurse practitioners, and registered dietitians. Pediatrics 110 1 Pt 2 (2002) 222-228
35. Magnussen C.G., Venn A., Thomson R., Juonala M., Srinivasan S.R., Viikari J.S., et al. The association of pediatric low- and high-density lipoprotein cholesterol dyslipidemia classifications and change in dyslipidemia status with carotid intima-media thickness in adulthood evidence from the cardiovascular risk in Young Finns study, the Bogalusa Heart study, and the CDAH (Childhood Determinants of Adult Health) study. J Am Coll Cardiol 53 10 (2009) 860-869
36. Wallace RB. Screening for early and asymptomatic conditions. In: Wallace RB, Kohatsu N, editors. Maxcy-Rosenau-Last Public Health and preventive medicine. 15th ed. New York: McGraw-Hill Medical. p. 1043-1045.
37. Murray C.J., Lauer J.A., Hutubessy R.C., Niessen L., Tomijima N., Rodgers A., et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 361 9359 (2003 Mar 1) 717-725
38. Griffin T.C., Christoffel K.K., Binns H.J., and McGuire P.A. Family history evaluation as a predictive screen for childhood hypercholesterolemia. Pediatric practice research group. Pediatrics 84 2 (1989) 365-373
39. Diller P.M., Huster G.A., Leach A.D., Laskarzewski P.M., and Sprecher D.L. Definition and application of the discretionary screening indicators according to the National cholesterol education program for children and adolescents. J Pediatr 126 3 (1995) 345-352
40. Haney E.M., Huffman L.H., Bougatsos C., Freeman M., Steiner R.D., and Nelson H.D. Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US preventive services task force. Pediatrics 120 1 (2007) e189-e214
41. Klag M.J., Ford D.E., Mead L.A., He J., Whelton P.K., Liang K.Y., et al. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 328 (1993) 313-318
42. Rosenthal S.L., Knauer-Black S., Stahl M.P., Catalanotto T.J., and Sprecher D.L. The psychological functioning of children with hypercholesterolemia and their families: a preliminary investigation. Clin Pediatr (Phila) 32 (1993) 135-141
43. Minhas R., Humphries S.E., Qureshi N., Neil H.A.W., and on behalf of the NICE Guideline Development Group. Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia. Heart 95 (2009) 584-587
44. Gidding S.S., Dennison B.A., Birch L.L., Daniels S.R., Gillman M.W., Lichtenstein A.H., et al. Dietary recommendations for children and adolescents: a guide for practitioners: consensus statement from the American Heart Association. Circulation 112 13 (2005) 2061-2075
45. Viikari J., Niinikoski H., Raitakari O.T., and Simell O. The initiatives and outcomes for cardiovascular risks that can be achieved through pediatric counseling. Curr Opin Lipidol 1 (2009) 17-23
46. Writing Group for the DISC Collaborative Research Group. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol: the dietary intervention study in children (DISC). J Am Med Assoc 273 18 (1995) 1429-1435
47. Salo P., Viikari J., Hämäläinen M., Lapinleimu H., Routi T., Rönnemaa T., et al. Serum cholesterol ester fatty acids in 7- and 13-month-old children in a prospective randomized trial of a low-saturated fat, low-cholesterol diet: the STRIP baby project. Special Turku coronary risk factor intervention project for children. Acta Paediatr 88 5 (1999) 505-512
48. Rask-Nissilä L., Jokinen E., Terho P., Tammi A., Lapinleimu H., Rönnemaa T., et al. Neurological development of 5-year-old children receiving a low-saturated fat, low-cholesterol diet since infancy: a randomized controlled trial. J Am Med Assoc 284 (2000) 993-1000
49. Owen C.G., Whincup P.H., Odoki K., Gilg J.A., and Cook D.G. Infant feeding and blood cholesterol: a study in adolescents and a systematic review. Pediatrics 110 (2002) 597-608
50. Owen C.G., Whincup P.H., Kaye S.J., Martin R.M., Davey Smith G., Cook D.G., et al. Does initial breastfeeding lead to lower blood cholesterol in adult life? A quantitative review of the evidence. Am J Clin Nutr 88 2 (2008) 305-314
51. Kaitosaari T., Rönnemaa T., Raitakari O., Talvia S., Kallio K., Volanen I., et al. Effect of 7-year infancy onset dietary intervention on serum lipoproteins and lipoprotein subclasses in healthy children in the prospective, randomized special Turku coronary risk factor intervention project for children (STRIP) study. Circulation 108 (2003) 672-677
52. Kavey R.E., Daniels S.R., Lauer R.M., Atkins D.L., Hayman L.L., and Taubert K. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation 107 11 (2003) 1562-1566 co-published in J Pediatr. 2003;142(4):368-372
53. Williams C.L., Bollella M., Spark A., and Puder D. Soluble fiber enhances the hypocholesterolemic effect of the step I diet in childhood. J Am Coll Nutr 14 (1995) 251-257
54. Davidson M.H., Dugan L.D., Burns J.H., Sugimoto D., Story K., and Drennan K. A psyllium-enriched cereal for the treatment of hypercholesterolemia in children: a controlled, double-blind, crossover study. Am J Clin Nutr 63 (1996) 96-102
55. Lichtenstein A.H., Deckelbaum R.J., and American Heart Association Science Advisory. Stanol/sterol ester-containing foods and blood cholesterol levels: a statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation 103 8 (2001) 1177-1179
56. Tammi A., Rönnemaa T., Miettinen T.A., Gylling H., Rask-Nissilä L., Viikari J., et al. Effects of gender, apolipoprotein E phenotype and cholesterol-lowering by plant stanol esters in children: the STRIP study. Special Turku Coronary Risk Factor Intervention Project. Acta Paediatr 91 (2002) 1155-1162
57. Gylling H., Siimes M.A., and Miettinen T.A. Sitostanol ester margarine in dietary treatment of children with familial hypercholestereolemia. J Lipid Res 36 (1995) 1807-1812
58. Costa R.L., and Summa M.A. Soy protein in the management of hyperlipidemia. Ann Pharmacother 34 7-8 (2000) 931-935
59. Taku K., Umegaki K., Sato Y., Taki Y., Endoh K., and Watanabe S. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr 85 4 (2007) 1148-1156
60. Gaddi A., Descovich G.C., Noseda G., Fragiacomo C., Nicolini A., Montanari G., et al. Hypercholesterolaemia treated by soybean protein diet. Arch Dis Child 62 (1987) 274-278
61. Widhalm K. Effect of diet on serum lipids and lipoprotein in hyperlipoproteinemic children. In: Beynen A.C. (Ed). Nutritional effects on cholesterol metabolism (1986), Transmondial, Voorthuizen, The Netherlands 133-140
62. Laurin D., Jacques H., Moorjani S., Steinke F.H., Gagné C., Brun D., et al. Effects of a soy-protein beverage on plasma lipoproteins in children with familial hypercholesterolemia. Am J Clin Nutr 54 (1991) 98-103
63. Jacques H., Laurin D., Moorjani S., Steinke F.H., Gagné C., Brun D., et al. Influence of diets containing cow's milk or soy protein beverage on plasma lipids in children with familial hypercholesterolemia. J Am Coll Nutr 11 (1992) 69S-73S
64. Engler M.M., Engler M.B., Malloy M.J., Paul S.M., Kulkarni K.R., and Mietus-Snyder M.L. Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study). Am J Cardiol 95 (2005) 869-871
65. McCrindle B.W., Helden E., and Conner W.T. Garlic extract therapy in children with hypercholesterolemia. Arch Pediatr Adolesc Med 152 (1998) 1089-1094
66. American Academy of Pediatrics, and Committee on nutrition. Cholesterol in childhood. Pediatrics 101 1 (1998) 141-147
67. Cook S. Hypercholesterolemia among children: when is it high, and when is it really high?. Circulation 119 8 (2009) 1075-1077
68. The 3rd report of the expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III: ATP III). J Am Med Assoc 285 19 (2001) 2486-2497
69. Hayward R.A., Hofer T.P., and Vijan S. Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem. Ann Intern Med 145 7 (2006) 520-530
70. Civeira F., Ros E., Jarauta E., Plana N., Zambon D., Puzo J., et al. Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia. Am J Cardiol 102 9 (2008) 1187-1193
71. American Heart Association Scientific Statement. Cardiovascular risk reduction in high-risk pediatric patients. Cardiovascular risk reduction in high-risk pediatric populations. Pediatrics 119 3 (2007) 618-621
72. Rubins H.B., Robins S.J., Collins D., Fye C.L., Anderson J.W., Elam M.B., et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans affairs high-density lipoprotein cholesterol intervention trial study group. N Engl J Med 341 6 (1999) 410-418
73. de Ferranti S., and Ludwig D.S. Storm over statins-the controversy surrounding pharmacologic treatment of children. N Engl J Med 359 13 (2008) 1309-1312
74. Colletti R.B., Neufeld E.J., Roff N.K., McAuliffe T.L., Baker A.L., and Newburger J.W. Niacin treatment of hypercholesterolemia in children. Pediatrics 92 (1993) 78
75. Yamaoka-Tojo M., Tojo T., and Izumi T. Beyond cholesterol lowering: pleiotropic effects of bile acid binding resins against cardiovascular disease risk factors in patients with metabolic syndrome. Curr Vasc Pharmacol 6 4 (2008) 271-281
76. McCrindle B.W., O'Neill M.B., Cullen-Dean G., and Helden E. Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial. J Pediatr 130 2 (1997) 266-273
77. Stein E.A., Marais D., Szamosi D., Raal F., Schurr D., Urbina E.M., et al. Efficacy and safety of colesevelam HCl in pediatric patients with heterozygous familial hypercholesterolemia. Circulation 118 (2008) S_469
78. Belay B., Belamarich P.F., and Tom-Revzon C. The use of statins in pediatrics: knowledge base, limitations, and future directions. Pediatrics 119 2 (2007) 370-380
79. Haney E.M., Huffman L.H., Bougatsos C., Freeman M., Steiner R.D., and Nelson H.D. Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US preventive services task force. Pediatrics 120 1 (2007) e189-e214
80. Arambepola C., Farmer A.J., Perera R., and Neil H.A. Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis. Atherosclerosis 195 2 (2007) 339-347
81. Van der Graaf A., Cuffie-Jackson C., Vissers M.N., Trip M.D., et al. Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia. J Am Coll Cardiol 52 17 (2008) 1421-1429
82. Al Badarin F.J., Kullo I.J., Kopecky S.L., and Thomas R.J. Impact of ezetimibe on atherosclerosis: is the jury still out?. Mayo Clin Proc 84 4 (2009) 353-361